Remedy Entertainment Oyj Stock

Equities

REMEDY

FI4000251897

Software

Market Closed - Nasdaq Helsinki 11:29:52 2024-04-26 am EDT 5-day change 1st Jan Change
18.72 EUR +14.15% Intraday chart for Remedy Entertainment Oyj +12.36% -26.30%
Sales 2024 * 53.84M 57.57M Sales 2025 * 67.8M 72.49M Capitalization 254M 271M
Net income 2024 * -9M -9.62M Net income 2025 * -3M -3.21M EV / Sales 2024 * 4.51 x
Net cash position 2024 * 10.8M 11.55M Net cash position 2025 * 9.65M 10.32M EV / Sales 2025 * 3.6 x
P/E ratio 2024 *
-59.4 x
P/E ratio 2025 *
64.6 x
Employees 352
Yield 2024 *
-
Yield 2025 *
0.59%
Free-Float 58.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+14.15%
1 week+12.36%
Current month+14.57%
1 month+14.71%
3 months-23.44%
6 months-30.67%
Current year-26.30%
More quotes
1 week
16.30
Extreme 16.3
19.68
1 month
16.10
Extreme 16.1
19.68
Current year
15.66
Extreme 15.66
26.50
1 year
15.66
Extreme 15.66
30.65
3 years
15.66
Extreme 15.66
49.00
5 years
7.76
Extreme 7.76
49.90
10 years
5.60
Extreme 5.6
49.90
More quotes
Managers TitleAgeSince
Founder 50 95-07-31
Chief Executive Officer 50 16-08-11
Director of Finance/CFO 53 17-12-31
Members of the board TitleAgeSince
Director/Board Member 53 17-03-31
Founder 50 95-07-31
Director/Board Member 45 22-03-21
More insiders
Date Price Change Volume
24-04-26 18.72 +14.15% 63,785
24-04-25 16.4 -0.73% 8,348
24-04-24 16.52 -2.02% 2,746
24-04-23 16.86 +0.72% 2,712
24-04-22 16.74 +0.48% 2,921

Delayed Quote Nasdaq Helsinki, April 26, 2024 at 11:29 am EDT

More quotes
Remedy Entertainment Oyj is a Finland-based game developer. The Company creates cinematic story-driven action console and computer games, which are published by partners, such as Microsoft, Rockstar Games and Smile Gate. The Company’s titles include Death Rally, Max Payne, Max Payne 2: The Fall of Max Payne, Alan Wake, Alan Wake's American Nightmare and Quantum Break, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18.72 EUR
Average target price
21.67 EUR
Spread / Average Target
+15.74%
Consensus
  1. Stock Market
  2. Equities
  3. REMEDY Stock